Growth Opportunity Analysis in the Global Biologics Outsourcing Market
$2,800.00 – $5,440.00
Increasing demand for the highly efficient biotherapeutics from the value-centric patient population globally is propelling the market growth
Innovative products and services such as nanobodies, rDNA, synthetic vaccines, and immunotherapeutics have emerged in the biologics industry in the last few years as part of the industry’s rapid expansion in the sector. Hybrid structures, which combine biologics with well-defined chemical entities, have had numerous opportunities to be explored in this industry.
Due to the rapid expansion of the biologics industry, an increase in outsourcing biologics development and manufacturing is to be expected. Biologics have gained wide applications in Stem Cell Research, Vaccine and Therapeutics Development, Blood & Blood-Related Products Development, and Cellular and Gene Therapy Products Development, among others.
The global biologics outsourcing market is expected to grow at a robust CAGR of 12.5% over the forecast period 2022-2028. The pace of biological drug development is increasing and is undergoing an increasing number of clinical trials. Outsourcing partners with platform solutions and specialized knowledge, expertise, and technologies are sought after by many pharmaceutical companies to develop cost-effective methods. Biologics outsourcing market growth will be stifled by high capital, technical, regulatory, and customer acquisition costs. Despite being very expensive when compared to conventional small molecule drugs, biologics are proven to be very beneficial for patients and also ensure higher profit margins for the drug manufacturers.
Outsourcing biologics development and manufacturing to provide ample growth opportunities
The biologics industry is growing at a rapid pace although with a lack of in-house biologics development and manufacturing capabilities. Biopharmaceutical companies’ drug manufacturing capacities have stimulated them to outsource the several aspects of biologics development and manufacturing process to highly efficient service providers.
Moreover, outsourcing services to other organizations such as contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and contract manufacturing organizations (CMOs) enable large biopharmaceutical companies to cut down on their operational costs and focus more on their core competencies. These organizations ensure congruity between demand and supply thereby speeding up the drug discovery and manufacturing process and also making it more convenient. This further brings the life-saving drugs to the market and ultimately to needy patients as early as possible.
Substantial growth in the Asia Pacific is expected
Asia Pacific biologics outsourcing market is expected to grow on account of the increase in non-communicable diseases coupled with an increase in the demand for biologics. Moreover, growth in the pharmaceutical sector in emerging markets along with an increase in government initiatives to improve healthcare facilities across the economies of the region is propelling the growth of the biologics outsourcing market.
Companies from around the globe are making significant investments in China and India to outsource their biologics research and development, which is further acting as a major growth factor for the market. Additionally, developed regions such as North America and Europe are expected to maintain their market share in the global market due to rising government support, increased adoption of technology in healthcare, favorable reimbursement initiatives, and rising demand for quality diagnostics and treatments.
Market Structure and Competition Landscape
The global biologics outsourcing market is characterized by the presence of a significant number of players. Some of the prominent players operating in the market include Lonza Group AG, Wuxi Biologics (Cayman) Inc., Boehringer Ingelheim International GmbH, Abzena Limited, GL Biochem Corp., Catalent Inc., Samsung Biologics Co. Ltd., ThermoFisher Scientific Inc., Syngene International Ltd., Rentschler Biopharma SE, Abbvie Inc. and Genescript Biotech Corp., among others. Growing focus on biologics and increasing R&D spending on biologics drugs by these industry players are expected to drive the market. Some of the key developments in the global biologics outsourcing market include:
- In April 2022, FUJIFILM Diosynth Biotechnologies (FUJIFILM Corp.) completed the acquisition of Atara Biotherapeutics Inc.’s dedicated cell therapy manufacturing facility. FUJIFILM seeks to manufacture cell therapies for other companies in addition to Atara by using this facility.
- In January 2022, Samsung Biologics agreed to pay US$ 2.3 billion for Biogen’s 50% stake in Samsung Bioepis, a joint venture between the two companies. This is aimed to improve Samsung Bioepis’ biosimilar development capabilities and future performance in new drug development.
- In March 2021, WuXi acquired a single-use biologics production plant in Hangzhou, China, from Pfizer Inc.
- In September 2020, Biocon Biologics Ltd. and Mylan announced the launch of biosimilar Semglee. This biosimilar is intended to control high blood pressure in adults with type-2 diabetes and pediatric patients with type-1 diabetes.
- In January 2020, True North, an Indian private equity fund, announced that it had acquired around 3% of Biocon Biologics India Ltd., for US$ 100 Million.
Key Market Segmentation
RationalStat has segmented the global biologics outsourcing market on the basis of product type, source, application, end use, and region.
- By Product Type
- Antibodies
- Monoclonal Antibody
- Antibody Drug Conjugates
- Others (Polyclonal Antibodies etc.)
- Recombinant Proteins
- Vaccines
- Others (Fusion Proteins, etc.)
- Antibodies
- By Source
- Human
- Microbial
- Others (Transgenic Animals such as Avian, Insects, etc.)
- By Application
- Stem Cell Research
- Vaccine and Therapeutics Development
- Blood & Blood-Related Products Development
- Cellular and Gene Therapy Products Development
- Others (Tissue & Tissue Related Products Development)
- By End Use
- Therapeutics and Diagnostics
- Research
- By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Western Europe
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- South Africa
- Turkey
- Rest of the Middle East & Africa
- North America
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecast, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Secondary Sources
- Annual reports, company filings, investor presentations, industry associations, product catalogues, and company documents
- Industry and market-related documents available in the public domain
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, and Thomson Reuters, among others
- Whitepapers, research papers, and industry blogs.
Why Buy this Report?
The report is intended for pharmaceutical companies, biotechnology and biologics companies, healthcare facilities, government organizations, educational organizations, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption pattern, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global biologics outsourcing market is expected to grow at a CAGR of over 12.5% during the forecast period 2022-2028.
Global biologics outsourcing is expected to reach over US$ 22.5 billion by 2028.
Biologics outsourcing for stem cell research is one of the key trends in the market.
North America is dominating the market in 2021.
Major companies operating in the global biologics outsourcing market are Lonza Group AG, Wuxi Biologics (Cayman) Inc., Boehringer Ingelheim International GmbH, etc.
| REGION | Global |
|---|---|
| RELEASE YEAR | 2022 |
| RESEARCH CODE | RST-SAR-023 |
| ADDITIONAL FEATURE | 24×7 Post sales support and 15% free customization |
| User License | Single User/Team License, Corporate License |
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players’ expenditures, and economic conditions among others
6.3. Supply Chain & Value Chain Analysis
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Rules & Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global Biologics Outsourcing Market: Key Investment Analysis
9.1. By Leading Biologics Companies
9.2. Technological Assessment
9.3. By Region
9.4. M&A Activities
Robust assessment of major investments made by various industry players along with key technological assessment, and key end-use sector
10. Global Biologics Outsourcing Market: Service Cost Analysis
10.1. By Service Type
10.1.1. Antibody Production Service
10.1.2. Custom Monoclonal Antibody Production Service
10.1.3. Custom Polyclonal Antibody Production Service
10.1.4. Protein Production Service
10.1.5. Gene Editing Service
11. Global Biologics Outsourcing Market: Biological Development Phase Analysis
11.1. Discovery
11.2. Pre-Clinical
11.3. Clinical
11.4. Commercialization
12. Parent Market Overview
12.1. Global Life Sciences Market
12.2. Global Healthcare Market
13. Segmental Analysis
13.1. Global Biologics Outsourcing Market by Product Type
13.1.1. Segment Overview
13.1.1.1. Antibodies
13.1.1.1.1. Monoclonal Antibody
13.1.1.1.2. Antibody Drug Conjugates
13.1.1.1.3. Others (Polyclonal Antibodies etc.)
13.1.1.2. Recombinant proteins
13.1.1.3. Vaccines
13.1.1.4. Others (Fusion Proteins, etc.)
13.2. Global Biologics Outsourcing Market by Source
13.2.1. Segment Overview
13.2.1.1. Human
13.2.1.2. Microbial
13.2.1.3. Others (Transgenic Animals such as Avian, Insects, etc.)
13.3. Global Biologics Outsourcing Market by Application
13.3.1. Segment Overview
13.3.1.1. Stem Cell Research
13.3.1.2. Vaccine and Therapeutics Development
13.3.1.3. Blood & Blood-Related Products Development
13.3.1.4. Cellular and Gene Therapy Products Development
13.3.1.5. Others (Tissue & Tissue Related Products Development)
13.4. Global Biologics Outsourcing Market by End Use
13.4.1. Segment Overview
13.4.1.1. Therapeutics and Diagnostics
13.4.1.2. Research
13.5. Global Biologics Outsourcing Market by Region
13.5.1. North America
13.5.2. Latin America
13.5.3. Western Europe
13.5.4. Eastern Europe
13.5.5. Asia Pacific
13.5.6. Middle East & Africa
14. Regional Analysis
14.1. North America Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.1.1. Market Overview
14.1.2. North America Biologics Outsourcing Market by Product Type
14.1.3. North America Biologics Outsourcing Market by Source
14.1.4. North America Biologics Outsourcing Market by Application
14.1.5. North America Biologics Outsourcing Market by End Use
14.1.6. North America Biologics Outsourcing Market by Country
14.1.6.1. US
14.2. Latin America Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.2.1. Market Overview
14.2.2. Latin America Biologics Outsourcing Market by Product Type
14.2.3. Latin America Biologics Outsourcing Market by Source
14.2.4. Latin America Biologics Outsourcing Market by Application
14.2.5. Latin America Biologics Outsourcing Market by End Use
14.2.6. Latin America Biologics Outsourcing Market by Country
14.2.6.1. Brazil
14.2.6.2. Mexico
14.2.6.3. Rest of Latin America
14.3. Western Europe Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.3.1. Market Overview
14.3.2. Western Europe Biologics Outsourcing Market by Product Type
14.3.3. Western Europe Biologics Outsourcing Market by Source
14.3.4. Western Europe Biologics Outsourcing Market by Application
14.3.5. Western Europe Biologics Outsourcing Market by End Use
14.3.6. Western Europe Biologics Outsourcing Market by Country
14.3.6.1. Germany
14.3.6.2. UK
14.3.6.3. France
14.3.6.4. Spain
14.3.6.5. Italy
14.3.6.6. Benelux
14.3.6.7. Nordic
14.3.6.8. Rest of Western Europe
14.4. Eastern Europe Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.4.1. Market Overview
14.4.2. Eastern Europe Biologics Outsourcing Market by Product Type
14.4.3. Eastern Europe Biologics Outsourcing Market by Source
14.4.4. Eastern Europe Biologics Outsourcing Market by Application
14.4.5. Eastern Europe Biologics Outsourcing Market by End Use
14.4.6. Eastern Europe Biologics Outsourcing Market by Country
14.4.6.1. Russia
14.4.6.2. Poland
14.4.6.3. Rest of Eastern Europe
14.5. Asia Pacific Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.5.1. Market Overview
14.5.2. Asia Pacific Biologics Outsourcing Market by Product Type
14.5.3. Asia Pacific Biologics Outsourcing Market by Source
14.5.4. Asia Pacific Biologics Outsourcing Market by Application
14.5.5. Asia Pacific Biologics Outsourcing Market by End Use
14.5.6. Asia Pacific Biologics Outsourcing Market by Country
14.5.6.1. China
14.5.6.2. Japan
14.5.6.3. India
14.5.6.4. South Korea
14.5.6.5. Australia
14.5.6.6. ASEAN
14.5.6.7. Rest of Asia-Pacific
14.6. Middle East & Africa Biologics Outsourcing Market Analysis and Forecast 2019-2028
14.6.1. Market Overview
14.6.2. Middle East & Africa Biologics Outsourcing Market by Product Type
14.6.3. Middle East & Africa Biologics Outsourcing Market by Source
14.6.4. Middle East & Africa Biologics Outsourcing Market by Application
14.6.5. Middle East & Africa Biologics Outsourcing Market by End Use
14.6.6. Middle East & Africa Biologics Outsourcing Market by Country
14.6.6.1. GCC
14.6.6.2. South Africa
14.6.6.3. Turkey
14.6.6.4. Rest of the Middle East & Africa
15. Competitive Landscape
15.1. Competition Dashboard
15.1.1. Global and Regional Market Share Analysis
15.1.2. Market Structure
15.2. Competitive Benchmarking
15.3. Key Strategy Analysis
15.4. Company Profiles
15.4.1. Lonza Group AG
15.4.1.1. Company Overview
15.4.1.2. Product/Service Offerings
15.4.1.3. Key Financials
15.4.1.4. Recent Developments
15.4.2. Wuxi Biologics (Cayman) Inc.
15.4.2.1. Company Overview
15.4.2.2. Product/Service Offerings
15.4.2.3. Financials
15.4.2.4. Recent Developments
15.4.3. Boehringer Ingelheim International GmbH
15.4.3.1. Company Overview
15.4.3.2. Product/Service Offerings
15.4.3.3. Financials
15.4.3.4. Recent Developments
15.4.4. Abzena Ltd.
15.4.4.1. Company Overview
15.4.4.2. Product/Service Offerings
15.4.4.3. Financials
15.4.4.4. Recent Developments
15.4.5. GL Biochem Corp.
15.4.5.1. Company Overview
15.4.5.2. Product/Service Offerings
15.4.5.3. Financials
15.4.5.4. Recent Developments
15.4.6. Catalent, Inc.
15.4.6.1. Company Overview
15.4.6.2. Product/Service Offerings
15.4.6.3. Financials
15.4.6.4. Recent Developments
15.4.7. Samsung Biologics Co.Ltd.
15.4.7.1. Company Overview
15.4.7.2. Product/Service Offerings
15.4.7.3. Financials
15.4.7.4. Recent Developments
15.4.8. ThermoFisher Scientific Inc.
15.4.8.1. Company Overview
15.4.8.2. Product/Service Offerings
15.4.8.3. Financials
15.4.8.4. Recent Developments
15.4.9. Syngene International Ltd.
15.4.9.1. Company Overview
15.4.9.2. Product/Service Offerings
15.4.9.3. Financials
15.4.9.4. Recent Developments
15.4.10. Rentschler Biopharma SE
15.4.10.1. Company Overview
15.4.10.2. Product/Service Offerings
15.4.10.3. Financials
15.4.10.4. Recent Developments
15.4.11. Abbvie Inc.
15.4.11.1. Company Overview
15.4.11.2. Product/Service Offerings
15.4.11.3. Financials
15.4.11.4. Recent Developments
15.4.12. Genscript Biotech Corp.
15.4.12.1. Company Overview
15.4.12.2. Product/Service Offerings
15.4.12.3. Financials
15.4.12.4. Recent Developments
*List of companies is not exhaustive
16. Disclaimer
List of Figures/Tables
List of Figures
Figure 01: Global Biologics Outsourcing Market Value Analysis (US$ Mn), 2019-2021
Figure 02: Global Biologics Outsourcing Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022–2028
Figure 03: Global Biologics Outsourcing Market Size and Market Share Analysis (%) by Product Type, 2022 & 2028
Figure 04: Global Biologics Outsourcing Market Y-o-Y Analysis (%) by Product Type, 2022-2028
Figure 05: Global Biologics Outsourcing Market Size and Market Share Analysis (%) by Source, 2022 & 2028
Figure 06: Global Biologics Outsourcing Market Y-o-Y Analysis (%) by Source, 2022-2028
Figure 07: Global Biologics Outsourcing Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 08: Global Biologics Outsourcing Market Y-o-Y Analysis (%) by Application, 2022-2028
Figure 09: Global Biologics Outsourcing Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 10: Global Biologics Outsourcing Market Y-o-Y Analysis (%) by End Use, 2022-2028
Figure 11: Global Biologics Outsourcing Market Size and Market Share Analysis (%) by Region, 2022 & 2028
Figure 12: Global Biologics Outsourcing Market Y-o-Y Growth (%) by Region, 2022–2028
Figure 13: North America Biologics Outsourcing Market Size and Market Share Analysis (%) by Product Type, 2022 & 2028
Figure 14: North America Biologics Outsourcing Market Size and Market Share Analysis (%) by Source, 2022 & 2028
Figure 15: North America Biologics Outsourcing Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 16: North America Biologics Outsourcing Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 17: North America Biologics Outsourcing Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 18: Latin America Biologics Outsourcing Market Size and Market Share Analysis (%) by Product Type, 2022 & 2028
Figure 19: Latin America Biologics Outsourcing Market Size and Market Share Analysis (%) by Source, 2022 & 2028
Figure 20: Latin America Biologics Outsourcing Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 21: Latin America Biologics Outsourcing Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 22: Latin America Biologics Outsourcing Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 23: Western Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Product Type, 2022 & 2028
Figure 24: Western Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Source, 2022 & 2028
Figure 25: Western Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 26: Western Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 27: Western Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 28: Eastern Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Product Type, 2022 & 2028
Figure 29: Eastern Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Source, 2022 & 2028
Figure 30: Eastern Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 31: Eastern Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 32: Eastern Europe Biologics Outsourcing Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 33: Asia Pacific Biologics Outsourcing Market Size and Market Share Analysis (%) by Product Type, 2022 & 2028
Figure 34: Asia Pacific Biologics Outsourcing Market Size and Market Share Analysis (%) by Source, 2022 & 2028
Figure 35: Asia Pacific Biologics Outsourcing Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 36: Asia Pacific Biologics Outsourcing Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 37: Asia Pacific Biologics Outsourcing Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 38: Middle East & Africa Biologics Outsourcing Market Size and Market Share Analysis (%) by Product Type, 2022 & 2028
Figure 39: Middle East & Africa Biologics Outsourcing Market Size and Market Share Analysis (%) by Source, 2022 & 2028
Figure 40: Middle East & Africa Biologics Outsourcing Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 41: Middle East & Africa Biologics Outsourcing Market Size and Market Share Analysis (%) by End Use, 2022 & 2028
Figure 42: Middle East & Africa Biologics Outsourcing Market Size and Market Share Analysis (%) by Country, 2022 & 2028
List of Tables
Table 1: Global Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product Type
Table 2: Global Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Source
Table 3: Global Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 4: Global Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 5: Global Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Region
Table 6: North America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product Type
Table 7: North America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Source
Table 8: North America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 9: North America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 10: North America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 11: Latin America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product Type
Table 12: Latin America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Source
Table 13: Latin America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 14: Latin America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 15: Latin America Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 16: Western Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product Type
Table 17: Western Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Source
Table 18: Western Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 19: Western Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 20: Western Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 21: Eastern Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product Type
Table 22: Eastern Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Source
Table 23: Eastern Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 24: Eastern Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 25: Eastern Europe Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 26: Asia Pacific Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product Type
Table 27: Asia Pacific Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Source
Table 28: Asia Pacific Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 29: Asia Pacific Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End Use
Table 30: Asia Pacific Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 31: Middle East & Africa Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product Type
Table 32: Middle East & Africa Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Source
Table 33: Middle East & Africa Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 34: Middle East & Africa Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Operational Frequency
Table 35: Middle East & Africa Biologics Outsourcing Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Every Sample Includes
Research Methodology
Complete Table of Contents, List of Charts and Tables
Exclusive Facts & Illustrations
Related products
Healthcare & Pharmaceutical
Global Pharmacogenomics Market Analysis and Forecast, 2019-2028
Market Introduction The global pharmacogenomics market is expected to grow significantly over the forecast period due to the increasing demand for personalized medicine, advancements in genetic research, and the growing incidence of chronic diseases. The rise in the number of genetic tests and growing awareness about pharmacogenomics among healthcare professionals and patients are also contributing [...]
Healthcare & Pharmaceutical
Global Stem Cell Therapy Market: Investment & Growth Opportunity Analysis, 2019-2028
The increasing prevalence of chronic diseases and growing developments in the stem cell therapies are driving the market growth
Healthcare & Pharmaceutical
Initiatives taken by global health organizations for the HPV vaccines to fuel the market growth
Healthcare & Pharmaceutical
Global AI in Healthcare Market Analysis and Forecast, 2023-2030
Market Introduction: Key Takeaways The global AI in healthcare market is projected to grow at a CAGR of 42.8% during the forecast period 2023-2028, with an expected market size of US$ 45.2 billion by 2028. The increasing demand for AI-powered healthcare solutions, rising adoption of big data analytics in healthcare, and the need to reduce [...]
Healthcare & Pharmaceutical
Global Core Molecular Laboratory Market Analysis and Forecast 2019-2028
Technological advancements and the adoption of personalized treatment to augment to grow the market revenue
Healthcare & Pharmaceutical
Global Dialysis Concentrate Market Analysis & Forecast 2019-2028
Global market growth is being driven by an increase in dialysis patient mortality